Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
CADA, a novel antiretroviral drug with specific CD4 down-modulating activity — Kurt Vermeire (2002) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
CADA, a novel antiretroviral drug with specific CD4 down-modulating activity
Shared by
De Clercq Erik
KU Leuven
CADA, a novel antiretroviral drug with specific CD4 down-modulating activity
Article
2002
en
Authors
+5 more
KV
Kurt Vermeire
SH
Sigrid Hatse
De Clercq Erik
KU Leuven
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2002
CADA, a specific CD4 down-modulating compound with potent anti-HIV activity
Dominique Schols
,
Kurt Vermeire
,
Sigrid Hatse
,
K Dey
,
M Samala
,
A Sodoma
,
De Clercq Erik
,
Thomas W. Bell
Article
2001
A novel CD4 down-modulating compound with antiviral activity
Kurt Vermeire
,
Ying Zhang
,
Thomas W. Bell
,
M Samala
,
A Sodoma
,
Katrien Princen
,
De Clercq Erik
,
Dominique Schols
Article
2002
Specific CD4 down-modulating compounds with potent anti-HIV and HHV-7 activity
Thomas W. Bell
,
K. K. Dey
,
Jin Qian
,
M Samala
,
Emily Scarbrough
,
A Sodoma
,
Kurt Vermeire
,
De Clercq Erik
,
Dominique Schols
Article
2003
Anti-HIV activity profile of a highly specific CD4 receptor down-modulating compound
Kurt Vermeire
,
De Clercq Erik
,
K Dey
,
Thomas W. Bell
,
Dominique Schols
Article
2003
In vitro synergy between the CD4 down-modulating compound, CADA, and multiple anti-HIV drugs
Kurt Vermeire
,
Sigrid Hatse
,
De Clercq Erik
,
K Dey
,
M Samala
,
A Sodoma
,
Thomas W. Bell
,
Dominique Schols
Discussion(0)
No comments yet. Be the first to comment.